Sonoma Biotherapeutics, Inc.
Clinical trials sponsored by Sonoma Biotherapeutics, Inc., explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New RA drug enters first human safety trial Results expected Nov 2026 (estimated)
- New biologic shot aims to tame painful skin disease Results expected Nov 2026 (estimated)